Alivus Life Sciences ALIVUS.NS · INR

Its shares trade on NSE under the ticker ALIVUS.NS. It has been listed since 6 August 2021. In the fiscal year to 31 March 2026, it reported revenue of ₹25.52bn and net income of ₹5.64bn. At that date it held total assets of ₹39.83bn and shareholders' equity of ₹33.32bn.

Glenmark Life Sciences Ltd. engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2021-08-06. The Company’s product portfolio comprises of various therapeutic segments, which include cardiovascular (CVS) disease, central nervous system (CNS) disorders, diabetes, gastrointestinal health, oncology, pain management and anti-infectives. Its products include Adapalene, Alogliptin Benzoate, Amiodarone HCl, Esomeprazole Sodium, Eszopiclone, Etoricoxib, Omeprazole, Oxcarbazepine, Zolpidem Tartrate, Zonisamide and Voriconazole. The Company’s products also include Vildagliptin, Aprepitant, Bosentan, Cilostazol, Deferasirox, Fluconazole, Ivacaftor, Pirfenidone, Riluzole, Sucralfate, Ticagrelor, Telmisartan and Umifenovir. The Company’s research and development facilities are located at Mahape, Ankleshwar and Dahej in India and manufacturing facilities are located at Ankleshwar, Dahej, Mohol and Kurkumbh.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Hiren PatelNon-Executive Non-Independent Chairman of the Board
• Dr. Yasir RawjeeChief Executive Officer, Managing Director, Executive Director, since 2019₹134.2m
• Mr. Tushar MistryChief Financial Officer, Senior Vice President₹53.3m
• Mr. Sumantra MitraSenior Vice President - Human Resources, Head - Human Resources, since 2020₹10.3m
• Mr. Navin AgrawalSenior Vice President - Quality, Head - Corporate Quality
• Mr. Mathew GeorgeSenior Vice President - Regulatory Affairs, Head - Regulatory Affairs
• Mr. Rudalf CorrieaCompany Secretary, Compliance Officer₹3.0m
• Dr. Palle AcharyuluGroup Vice President, Head - Research and Development
• Mr. Vinod NaikHead - Technical Operations, Whole Time Director, since 2020₹57.4m
• Mrs. Manju AgarwalNon-Executive Independent Director₹1.4m
• Mr. Taruvai EaswarNon-Executive Independent Director₹1.2m
• Dr. Savan GodiawalaNon-Executive Independent Director₹900,000

Overall

38

Environment

33

Social

56

Governance

25

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.